Article
BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants.
Journal of neuropathology and experimental neurology - 1 Jan 2012
Lin Alex, Rodriguez Fausto J, Karajannis Matthias A, Williams Susan C, Legault Genevieve, Zagzag David, Burger Peter C, Allen Jeffrey C, Eberhart Charles G, Bar Eli E
Abstract excerpt
Recent studies highlight the importance of BRAF alterations resulting in mitogen activated protein kinase (MAK/ERK) pathway activation in low-grade CNS tumors. We studied 106 low-grade CNS neoplasms in a cohort of primarily pediatric patients to identify the prevalence and clinicopathologic significance of these alterations. Polymerase chain reaction testing identified KIAA1549:BRAF fusions in 51 (48%) tumors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
